Literature DB >> 10232695

Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease.

V Nickeleit1, H H Hirsch, I F Binet, F Gudat, O Prince, P Dalquen, G Thiel, M J Mihatsch.   

Abstract

Polyomavirus (PV) exceptionally causes a morphologically manifest renal allograft infection. Five such cases were encountered in this study, and were followed between 40 and 330 d during persistent PV renal allograft infection. Transplant (Tx) control groups without PV graft infection were analyzed for comparison. Tissue and urine samples were evaluated by light microscopy, immunohistochemistry, electron microscopy, and PCR. The initial diagnosis of PV infection with the BK strain was made in biopsies 9+/-2 mo (mean +/- SD) post-Tx after prior rejection episodes and rescue therapy with tacrolimus. All subsequent biopsies showed persistent PV infection. Intranuclear viral inclusion bodies in epithelial cells along the entire nephron and the transitional cell layer were histologic hallmarks of infection. Affected tubular cells were enlarged and often necrotic. In two patients, small glomerular crescents were found. In 54% of biopsies, infection was associated with pronounced inflammation, which had features of cellular rejection. All patients were excreting PV-infected cells in the urine. PV infection was associated with 40% graft loss (2 of 5) and a serum creatinine of 484+/-326 micromol/L (mean +/- SD; 11 mo post-Tx). Tx control groups showed PV-infected cells in the urine in 5%. Control subjects had fewer rejection episodes (P<0.05) and stable graft function (P = 0.01). It is concluded that a manifest renal allograft infection with PV (BK strain) can persist in heavily immunosuppressed patients with recurrent rejection episodes. PV mainly affects tubular cells and causes necrosis, a major reason for functional deterioration. A biopsy is required for diagnosis. Urine cytology can serve as an adjunct diagnostic tool.

Entities:  

Mesh:

Year:  1999        PMID: 10232695     DOI: 10.1681/ASN.V1051080

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  78 in total

Review 1.  BK polyomavirus: emerging pathogen.

Authors:  Shauna M Bennett; Nicole M Broekema; Michael J Imperiale
Journal:  Microbes Infect       Date:  2012-02-24       Impact factor: 2.700

2.  Molecular characterization of BK virus in patients infected with human immunodeficiency virus.

Authors:  Danijela Karalic; Ivana Lazarevic; Ana Banko; Maja Cupic; Djordje Jevtovic; Tanja Jovanovic
Journal:  Med Microbiol Immunol       Date:  2015-10-26       Impact factor: 3.402

3.  Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis.

Authors:  Melissa Krystel-Whittemore; Ellen T McCarthy; Ivan Damjanov; Timothy A Fields
Journal:  BMJ Case Rep       Date:  2015-08-28

4.  BKV-DNA and JCV-DNA co-quantification assay to evaluate viral load in urine and serum.

Authors:  Chiara Merlino; Massimiliano Bergallo; Roberta Daniele; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2005-05       Impact factor: 2.695

5.  Urine cytology screening for polyoma virus infection following renal transplantation: the Oxford experience.

Authors:  Thomas P Thamboo; Katie J M Jeffery; Peter J Friend; Gareth D H Turner; Ian S D Roberts
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

6.  Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.

Authors:  Nissreen Elfadawy; Stuart M Flechner; Jesse D Schold; Titte R Srinivas; Emilio Poggio; Richard Fatica; Robin Avery; Sherif B Mossad
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 8.237

7.  Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms.

Authors:  A Dumoulin; H H Hirsch
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

8.  Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.

Authors:  Ludmila Krymskaya; Madeva C Sharma; Joy Martinez; Wahajul Haq; Eric C Huang; Ajit P Limaye; Don J Diamond; Simon F Lacey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Antirejection treatment in kidney transplant patients with BK viruria.

Authors:  Liise K Kayler; Ibrahim Batal; Ravi Mohanka; Claire Morgan; Amit Basu; Ron Shapiro; Parmjeet S Randhawa
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

10.  Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.

Authors:  Parmjeet Randhawa; Raphael Viscidi; Joseph J Carter; Denise A Galloway; Tim D Culp; Cathy Huang; Bala Ramaswami; Neil D Christensen
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.